Cml Cp Or Cml Ap Patients With T315i Mutation clinical trials

Explore recruiting cml cp or cml ap patients with t315i mutation clinical trials.

Recruiting cml cp or cml ap patients with t315i mutation studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Cml Cp Or Cml Ap Patients With T315i Mutation trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase II, multi-center, prospective, open-label study of Asciminib in patients with Chronic Myeloid Leukemia in Chronic Phase (CML-CP) or accelerated Phase (CML-AP) with T315I mutation who are resistant, intolerant or ineligible to ponatinib (ASC4TARGET)

France

Therapeutic exploratory (Phase II) EU CTIS Study details

Cml Cp Or Cml Ap Patients With T315i Mutation trials by city

Cml Cp Or Cml Ap Patients With T315i Mutation in Toronto Cml Cp Or Cml Ap Patients With T315i Mutation in Vancouver Cml Cp Or Cml Ap Patients With T315i Mutation in Montreal Cml Cp Or Cml Ap Patients With T315i Mutation in Calgary Cml Cp Or Cml Ap Patients With T315i Mutation in Edmonton Cml Cp Or Cml Ap Patients With T315i Mutation in Ottawa Cml Cp Or Cml Ap Patients With T315i Mutation in Winnipeg Cml Cp Or Cml Ap Patients With T315i Mutation in Quebec City Cml Cp Or Cml Ap Patients With T315i Mutation in Hamilton Cml Cp Or Cml Ap Patients With T315i Mutation in Kitchener Cml Cp Or Cml Ap Patients With T315i Mutation in London Cml Cp Or Cml Ap Patients With T315i Mutation in Halifax Cml Cp Or Cml Ap Patients With T315i Mutation in New York Cml Cp Or Cml Ap Patients With T315i Mutation in Los Angeles Cml Cp Or Cml Ap Patients With T315i Mutation in Chicago Cml Cp Or Cml Ap Patients With T315i Mutation in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease